Menu

New Research Using Data from SART Patient Predictor Tool Assesses the Probability of Live Birth with One or More Cycles of Assisted Reproductive Therapy

Presenting their results at this year’s ASRM Scientific Congress, researchers using data analyzed from the Society for Assisted Reproductive Technology's (SART) Patient Predictor developed prediction models that estimate the cumulative probability of live birth over three complete cycles of in vitro fertilization (IVF).

Research presented by David McLernon, PhD, from the University of Aberdeen, Aberdeen, Scotland, UK, extracted linked fresh and frozen cycle data on women who underwent IVF in 2014-2016 from the SART Clinic Outcome Reporting System database.

Of 79,512 women who underwent 103,270 complete cycles, 46.3% had a live birth from the first complete cycle, and cumulatively, 55.6% had a live birth over three complete cycles.

“The SART Predictor Tool is a freely available resource for both patients and clinicians to help effectively manage the expectations of assisted reproductive therapy,” said Valerie Bake,r MD, SART President. “We hope that this latest research describing the SART Patient Predictor will provide individualized chances of success to help couples prepare emotionally and financially.”

The SART Predictor Tool also allows the patient to enter her antimüllerian hormone level (AMH), which is a predictor of response to ovarian stimulation. Recent research reporting cumulative live birth rate (CLBR) by assessing outcomes of all linked fresh and/or frozen embryo transfer cycles in 2014 to 2016 found that AMH is highly correlated with CLBR in women with diminished ovarian reserve (DOR) independent of age.

“Using AMH in current age-based prognostication counseling provides more informative and personalized CLBR prediction,” said Amy Sparks, PhD, SART Past President. “With the addition of individualized AMH assessment, the SART Predictor Tool continues to provide patients, clinicians and researchers in assisted reproductive therapy the most relevant and timely data.”

To learn more about the SART Predictor Tool visit https://www.sart.org/.

About ASRM
ASRM is a multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated healthcare providers. The Society is committed to facilitating and sponsoring educational activities for the lay public and continuing medical education activities for professionals who are engaged in the practice of and research in reproductive medicine. https://www.asrm.org  

About SART
SART is the primary organization of professionals dedicated to the practice of IVF, or assisted reproductive technology (ART). The organization represents the majority of ART clinics in the country. The mission of SART is to establish and maintain standards for ART so that patients receive the highest possible level of care.

The ASRM Bulletin is published by ASRM's Office of Public Affairs to inform Society members of important recent developments. Republication or any other use of the contents of the Bulletin without permission is prohibited. To request permission to quote or excerpt material from the Bulletin, contact Sean Tipton at stipton@asrm.org.   

ReproductiveFacts.org
is a patient education website of ASRM.
 

RFSubscribe.jpg